Old Web
English
Sign In
Acemap
>
authorDetail
>
David A. Wilfret
David A. Wilfret
Hepatitis C virus
Cmax
Pharmacology
Medicine
Pharmacokinetics
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects
2014
Clinical pharmacology in drug development
David A. Wilfret
Jill Walker
Christian Voitenleitner
Sharon Baptiste‐Brown
Mark Lovern
Joseph Kim
Kimberly K. Adkison
Brad Shotwell
Amanda Mathis
Lee Moss
Daniel J. Lee
Lou Yu
Jianjun Gan
Andrew Spaltenstein
Show All
Source
Cite
Save
Citations (3)
Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adults
2014
Clinical pharmacology in drug development
Kimberly K. Adkison
Lori S. Jones
Yu Lou
Jianjun Gan
David A. Wilfret
Show All
Source
Cite
Save
Citations (1)
1